Preparation and evaluation of As2O3 nanoparticles for treatment of human liver cancer cells in vitro

Journal of Southeast University (English Edition)

Volumn 21, Issue 1, 2005, Pages 58-62

  Wang, Ziyu ^a   Zhang, Dongsheng ^a   Gu, Ning ^a   Lu, Xinli ^a   Yan, Shiyan ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Arsenic trioxide; Liver cancer; Nanotechnology

Indexed keywords

ARSENIC COMPOUNDS; CELLS; NANOTECHNOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

ANTITUMOR EFFECT; ASO NANOPARTICLES; COMPUTER COLOR MAGIC IMAGE ANALYSIS SYSTEM (CMIAS); ENERGY DISPERSIVE SPECTROMETER (EDS); FLOW CYTOMETRY (FCM) ASSAY; HUMAN LIVER CANCER CELLS; METHYL THIAZOLYL TETRAZOLIUM (MTT) ASSAY; PREPARATION METHOD; TRANSMISSION ELECTRON MICROSCOPE (TEM);

ONCOLOGY;

EID: 17244369298     PISSN: 10037985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Wang Z Y, Zhang D S. The advance in research of nano-medicine[J]. Journal of Southeast University (Medical Science Edition), 2004, 23(2): 131-135. (in Chinese)
2. Zhang P, Wang S Y, Hu L H, et al. Treatment of acute promyelocytic leukemia with intravenous arsenic trioxide[J]. Chinese Journal of Hematology, 1996, 17: 58-60. (in Chinese)
3. Jing Y, Xia L, Waxman S. Targeted removal of PMLRAR alpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia[J]. Blood, 2002, 100(3): 1008-1013.
4. Woo S H, Park I C, Park M J, et al. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells[J]. International Journal of Oncology, 2002, 21(1): 57-63.
5. Shen Z Y, Shen J, Cai W J, et al. The alteration of mitochondria is an early event of arsenic trioxide induced apoptosis in esophageal carcinoma cells[J]. International Journal of Molecular Medicine, 2000, 5(2): 155-158.
6. Zhang T C, Cao E H, Li J F, et al. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide[J]. European Journal of Cancer, 1999, 35(8): 1258-1263.
7. Du C W, Li D R, Lin Y C, et al. Arsenic trioxide induces differentiation of human nasopharyngeal carcinoma in BALB/C nude mice xenograft model[J]. Chinese Journal of Cancer, 2003, 22(1): 21-25. (in Chinese)
8. Yu D, Wang Z H, Cheng S B, et al. The effect of arsenic trioxide on the expression of Hsc and HNF4 in nuclear matrix proteins in HepG2 cells[J]. Anticancer Research, 2001, 21(4A): 2553-2559.
9. Uslu R, Sanli U A, Sezgin C, et al. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines[J]. Clinical Cancer Research, 2000, 6(12): 4957-4964.
10. Baj G; Arnulfo A, Deaglio S, et al. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects[J]. Breast Cancer Research and Treatment, 2002, 73(1): 61-73.
11. Zhou D F. Generality of materials[M]. Beijing: Chemical Industry Press, 2001. (in Chinese)
12. Sithinamsuwan P, Piratvisuth T, Tanomkiat W, et al. Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital[J]. World Journal of Gastroenterology, 2000, 6(3): 339-343.
13. Tang Z Y. Hepatocellular carcinoma: cause, treatment and metastasis[J]. World Journal of Gastroenterology, 2001, 7: 445-454.
14. Miller Wilson H Jr, Schipper Hyman M, Lee J S, et al. Mechanisms of action of arsenic trioxide[J]. Cancer Research, 2002, 62(14): 3893-3903.
15. Huang S Y, Chang C S, Tang J L, et al. Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia[J]. British Journal of Haematology, 1998, 103(4): 1092-1095.
16. Hu X, Ma L, Hu N, et al. Ailing No. 1 in treating 62 cases of acute promyelocytic leukaemia[J]. Chinese Journal of Integrated Traditional and Western Medicine, 1999, 19(8): 473-476. (in Chinese)
17. Dong J T, Luo X M. Effects of arsenic on DNA damage and repair in human fetal lung fibroblasts[J]. Mutation Research, 1994, 315: 11-15.
18. Tsai S M, Wang T N, Ko Y C, et al. Mortality for certain disease in areas with high levels of arsenic in drinking water[J]. Archives of Environmental Health, 1999, 54(3): 186-193.
19. Jung T, Kamm W, Breitenbach A, Kaiserling E, et al. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2000, 50(1): 147-160.
20. Ma M, Zhu Y, Zhang Y, et al. Preparation of magnetite nanoparticles and interaction with cancer cells[J]. Journal of Southeast University (Natural Science Edition), 2003, 33(2): 205-207. (in Chinese)
21. Zhang D S, Fan X S, Jia X P, et al. Effect of nano-magnetoliposomes containing arsenic trioxide on hela cells[J]. Chinese Journal of Traditional and Western Medicine, 2003, 4(9): 1289-1292.
22. Ying D, Xu Huibi, Huang Kaixun, et al. Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304[J]. Pharmacological Research, 2001, 44(6): 513-518.